Named one of the “Top Doctors” for oncology by Pasadena magazine since 2011, Joseph. Chao, M.D. joined City of Hope in 2007 as a Fellow and subsequently recruited on faculty in 2010 as an Assistant Clinical Professor with expertise on gastrointestinal, stomach,
esophageal, and colorectal cancers. He is currently leading clinical trial efforts to develop novel therapies for gastroesophageal cancers and is also conducting research to discover new blood biomarkers for this disease. His research has been recognized by the NIH
Paul Calabresi Career Development Award in Clinical Oncology for ongoing projects in immunotherapeutics and the development of microRNA biomarkers. Dr. Chao’s expertise has helped shape national treatment guidelines where he serves on the National Comprehensive Cancer Network (NCCN) panels for Gastric and Esophageal Cancers and is the current academic co-chair for Via Oncology Pathways in gastroesophageal malignancies.
Dr. Chao earned his medical degree at the University of Illinois at Chicago, then continued his training at Harbor-UCLA Medical Center.